Tc-99m Generators: Elution, Molybdenum Breakthrough, and Quality Control

Q: What is the Mo-99 breakthrough limit for a Tc-99m generator?

The NRC limit in 10 CFR 35.204 is 0.15 microcurie of Mo-99 per millicurie of Tc-99m (0.15 kBq per MBq) at the time of administration to the patient. A licensee may not administer a dose that exceeds this ratio, and the first eluate of each elution day must be measured.

Q: How is Mo-99 breakthrough measured?

The Tc-99m eluate is placed in a lead shield (often about 6 mm of lead) that absorbs the 140 keV Tc-99m photons while passing the higher-energy 740 and 778 keV Mo-99 photons, and the assembly is assayed in a dose calibrator on the Mo-99 setting. The Mo-99 activity is then divided by the Tc-99m activity in the unshielded eluate to get the breakthrough ratio.

Q: What is the aluminum breakthrough limit for a Tc-99m generator?

For fission-produced Mo-99 generators, the USP limit is no more than 10 micrograms of aluminum per milliliter of eluate. It is tested colorimetrically with aluminum indicator paper, comparing the spot color against a standard, on each elution.

Q: How often must generator eluate be tested?

Mo-99 breakthrough is measured on the first eluate of each elution under 10 CFR 35.204, and aluminum, radiochemical purity, pH, and appearance are checked per the USP monograph and the facility QC program. Records must be retained for NRC or Agreement State inspection.

Q: Why does the Tc-99m generator have to sit before elution?

Tc-99m grows back in from its Mo-99 parent by transient equilibrium. After an elution that strips the column, Tc-99m activity rebuilds and peaks roughly 23 hours later, so a generator typically reaches near-maximum yield about a day after the prior elution.

Q: What is the difference between radionuclidic, radiochemical, and chemical purity?

Radionuclidic purity is the fraction of activity that is the correct radionuclide—violated by Mo-99 breakthrough. Radiochemical purity is the fraction of activity in the correct chemical form, such as pertechnetate rather than reduced or hydrolyzed technetium. Chemical purity concerns non-radioactive contaminants such as aluminum from the column.

Q: Who regulates Tc-99m generators?

Tc-99m and Mo-99 are byproduct material regulated by the NRC under 10 CFR 20 and 10 CFR 35, including the 35.204 breakthrough limits. In Agreement States such as Florida, Maryland, Virginia, California, and Nevada, an equivalent state program enforces the same limits, while Washington, DC is regulated directly by the NRC.

A Mo-99/Tc-99m generator delivers the most widely used radionuclide in nuclear medicine, and the quality-control tests run on every elution—molybdenum breakthrough, aluminum breakthrough, radiochemical purity, and pH/appearance—are what confirm the eluate is safe to inject and compliant with NRC and USP limits. The headline number is the NRC's molybdenum-99 limit in 10 CFR 35.204: no more than 0.15 µCi of Mo-99 per mCi of Tc-99m (0.15 kBq/MBq) at the time of administration, with the first eluate of each elution day measured and recorded. ¹

At Diagnostic Radiation Physics Services (DRPS), our board-certified medical physicists support nuclear medicine and PET/CT programs and their nuclear pharmacy QC across Florida, Maryland, Virginia, Washington DC, California, and Nevada, where generator handling drives both daily workflow and license compliance.

Introduction

The technetium-99m generator—often called a "moly cow" because it is "milked" for its daughter activity—is the single most important piece of equipment in a conventional nuclear medicine department. Tc-99m accounts for the large majority of all diagnostic nuclear medicine procedures worldwide, from bone and renal scans to myocardial perfusion and sentinel-node studies, because its 140 keV gamma photon and ~6-hour half-life are nearly ideal for the gamma camera and for patient dose. ²³

What makes the generator practical is the large half-life mismatch between the parent and the daughter. Molybdenum-99 (T½ ≈ 65.9 h) is long-lived enough to ship from a reactor and to last a working week in the clinic, while technetium-99m (T½ ≈ 6.0 h) grows back in fast enough to be eluted daily. That same physics—transient equilibrium—sets when to elute, how much yield to expect, and how to interpret the quality-control numbers. This guide walks through the elution chemistry, the parent–daughter math, every required eluate QC test with its limit and method, and the NRC and USP framework that governs the whole process. It is a companion to our dose calibrator quality control guide, since the dose calibrator is the instrument that makes the breakthrough measurement possible.

Topic Explanation

What is a Mo-99/Tc-99m generator?

A Mo-99/Tc-99m generator is a shielded column-chromatography device that holds the parent Mo-99 fixed on a solid support and lets the clinic separate the daughter Tc-99m on demand. Fission-produced Mo-99 (as molybdate, $MoO_{4}^{2 -}$ ) is adsorbed onto an acidic alumina ( $Al_{2} O_{3}$ ) column. As Mo-99 decays, it forms Tc-99m as pertechnetate ( $TcO_{4}^{-}$ ), which binds the alumina far more weakly than molybdate does. ³⁴

To harvest the Tc-99m, sterile, pyrogen-free 0.9% saline is drawn through the column under vacuum into an evacuated, shielded vial. The saline elutes the loosely bound pertechnetate while leaving the parent molybdate on the column. The result is sodium pertechnetate Tc-99m injection—the starting material for nearly every Tc-99m radiopharmaceutical kit. The act of drawing the eluate is the "elution," and stripping the column resets the daughter activity to near zero so it can grow back in for the next day.

Key terms

Elution: the process of drawing saline through the generator column to separate and collect Tc-99m pertechnetate. The collected liquid is the eluate.
Elution (yield) efficiency: the fraction of available Tc-99m that the saline actually removes from the column, typically high (often quoted around 80–90%) for a well-performing generator.
Breakthrough: unwanted material appearing in the eluate. Mo-99 breakthrough (parent passing into the daughter eluate) is a radionuclidic-purity failure; aluminum breakthrough (column $Al_{2} O_{3}$ leaching) is a chemical-purity failure.
Transient equilibrium: the condition reached when the parent half-life is moderately longer than the daughter half-life, so after several daughter half-lives the daughter activity slightly exceeds and then decays in parallel with the parent. This is the regime that governs Tc-99m buildup.
Radionuclidic, radiochemical, and chemical purity: three distinct purity concepts defined in the next section—the correct radionuclide, the correct chemical form, and freedom from chemical contaminants, respectively.

Radionuclidic vs. radiochemical vs. chemical purity

These three purities are frequently confused, and the eluate QC tests map directly onto them:

Radionuclidic purity is the fraction of total radioactivity present as the intended radionuclide. Mo-99 breakthrough degrades radionuclidic purity, because the long-lived, high-energy Mo-99 in the eluate is not the radionuclide you intend to inject. This is the purity that 10 CFR 35.204 protects. ¹
Radiochemical purity is the fraction of the activity present in the intended chemical form. For generator eluate, that means technetium in the +7 pertechnetate state ( $TcO_{4}^{-}$ ) rather than reduced or hydrolyzed technetium species, which would mislabel and biodistribute differently.
Chemical purity concerns non-radioactive contaminants—principally aluminum ion leached from the alumina column. Excess aluminum can cause colloid formation and altered biodistribution (for example, liver uptake of a bone agent), which is why it is capped and tested. ⁴

Key Technical Principles

The generator's behavior follows from one differential equation and three QC tests. The math tells you when to elute and how much to expect; the tests tell you whether the eluate is safe to use.

Transient equilibrium and Tc-99m buildup

After an elution strips the column, the Tc-99m daughter activity rebuilds from the decaying Mo-99 parent. The daughter activity as a function of time after a clean elution follows the Bateman parent–daughter relationship:

A_{T c} (t) = A_{M o, 0} \frac{λ _{T c}}{λ _{T c} - λ _{M o}} (e^{- λ_{M o} t} - e^{- λ_{T c} t})

where $A_{M o, 0}$ is the parent activity at the last elution, and $λ_{M o}$ and $λ_{T c}$ are the parent and daughter decay constants. (Strictly, the imaged Tc-99m branch is ~88% of Mo-99 decays, so a branching factor of about 0.88 is applied for the absolute activity; the timing of the peak below is unaffected.) ²⁵ With

λ_{M o} = \frac{ln 2}{65.9 h} \approx 0.01052 h^{- 1}, λ_{T c} = \frac{ln 2}{6.01 h} \approx 0.1153 h^{- 1}

the daughter activity rises, peaks, and then decays in parallel with the parent. Because $λ_{M o} < λ_{T c}$ but the two are within about one order of magnitude, this is transient (not secular) equilibrium: at the peak and beyond, the Tc-99m activity slightly exceeds the Mo-99 activity and the two then fall together with the 65.9 h parent half-life.

Optimal elution timing (~23 h)

The Tc-99m activity peaks when its time derivative is zero, which gives a closed-form expression for the buildup time:

t_{ma x} = \frac{ln ( λ _{T c} / λ _{M o} )}{λ _{T c} - λ _{M o}}

Substituting the decay constants above:

t_{ma x} = \frac{ln ( 0.1153/0.01052 )}{0.1153 - 0.01052} = \frac{ln ( 10.96 )}{0.1048 h ^{- 1}} \approx \frac{2.394}{0.1048} \approx 22.8 h

So the daughter reaches its maximum about 23 hours after a complete elution—the physical reason a generator eluted once daily is at near-peak yield each morning. Yield climbs steeply early: after a clean elution the column regenerates roughly half its eventual Tc-99m within the first ~6 hours, so a second "afternoon" elution the same day still recovers a useful, if smaller, amount. Elution timing is therefore a workflow lever, not just a curiosity: a department that needs extra activity for an add-on study can re-elute, accepting a lower yield governed by this same buildup curve.

Mo-99 breakthrough ratio—worked calculation

Mo-99 breakthrough is quantified as a ratio of Mo-99 activity to Tc-99m activity in the eluate, evaluated at the time of administration. The measurement uses energy discrimination: the eluate vial is placed inside a lead shield (commonly ~6 mm thick) that absorbs essentially all of the 140 keV Tc-99m photons but transmits the penetrating 740 keV and 778 keV Mo-99 photons. ¹⁶ The shielded vial is assayed in a dose calibrator on the Mo-99 channel; the unshielded vial gives the Tc-99m activity.

Suppose a fresh eluate assays at 1,000 mCi (37 GBq) of Tc-99m, and the shielded Mo-99 reading is 0.10 mCi (3.7 MBq) of Mo-99. The breakthrough ratio is:

Breakthrough = \frac{0.10 mCi Mo-99 \times 1000 ( μ Ci/mCi )}{1000 mCi Tc-99m} = \frac{100 μ Ci Mo-99}{1000 mCi Tc-99m} = 0.10 \frac{μ Ci Mo-99}{mCi Tc-99m}

That is 0.10 µCi/mCi, below the 0.15 µCi/mCi limit, so the eluate passes. The same eluate in SI units is 0.10 kBq Mo-99 per MBq Tc-99m, against the 0.15 kBq/MBq limit. ¹

Two consequences of the ratio form are worth internalizing. First, because Tc-99m decays much faster than Mo-99, the breakthrough ratio rises with time—an eluate that passes at calibration can exceed the limit hours later as the Tc-99m denominator shrinks. The limit applies "at the time of administration," so late-day or held doses deserve attention. Second, a single passing reading does not license the rest of the day; if the same eluate is split and a portion is used much later, the ratio at that later administration time is what governs.

Eluate QC test reference table

Every elution should be evaluated against a defined set of limits. The table consolidates the four core eluate QC tests, their limits, methods, and frequency. Confirm the exact numeric limits against the current 10 CFR 35.204 text and the USP sodium pertechnetate Tc 99m monograph your program adopts, since fission- and non-fission (e.g., neutron-activation or accelerator) sources can carry different aluminum and trace-contaminant expectations. ¹⁴

QC test	Purity type	Limit	Method	Frequency
Mo-99 breakthrough	Radionuclidic	≤ 0.15 µCi Mo-99 per mCi Tc-99m (0.15 kBq/MBq) at administration ¹	Lead-shielded vial (~6 mm Pb) assayed in dose calibrator on Mo-99 setting; divide Mo-99 by Tc-99m activity	First eluate of each elution (each elution day) ¹
Aluminum breakthrough	Chemical	≤ 10 µg Al per mL of eluate (fission Mo-99) ⁴⁷	Colorimetric aluminum indicator paper; compare spot color to standard	Each elution ⁴
Radiochemical purity	Radiochemical	Typically ≥ 95% as $TcO_{4}^{-}$	Instant thin-layer chromatography (ITLC) / paper chromatography with appropriate solvent	Per USP monograph / facility QC schedule
pH and appearance	Chemical / physical	Clear, colorless, particle-free; pH within the monograph range (about 4.5–7.5)	Visual inspection; pH paper or meter	Each elution

The Mitra et al. validation of a hospital-radiopharmacy generator, for example, reported eluate meeting all of these—Mo-99 breakthrough well under limit, Al and Mo content under 10 µg/mL, radiochemical purity above 98%, and pH between 5.0 and 6.5—illustrating what a healthy generator looks like across the full panel. ⁸

Clinical Impact

Generator QC is not paperwork for its own sake; each failed test maps to a concrete patient-safety or image-quality consequence:

Mo-99 breakthrough → unnecessary patient dose and license violation. Mo-99's long half-life (65.9 h) and high-energy betas and photons mean any breakthrough delivers absorbed dose with no diagnostic benefit, and an over-limit administration is a reportable compliance failure under 10 CFR 35.204. ¹
Aluminum breakthrough → degraded images. Excess $Al^{3 +}$ can flocculate certain Tc-99m agents and alter biodistribution—classically causing liver uptake on bone scans or poor red-cell labeling—turning a chemistry problem into a non-diagnostic study. ⁴
Low radiochemical purity → mislocalized activity. Free pertechnetate or reduced-hydrolyzed Tc-99m in a labeled kit shows up as stomach, thyroid, and salivary uptake (free $TcO_{4}^{-}$ ) or as liver/spleen colloid, confusing interpretation.
Supply reliability → access to nuclear medicine itself. The global Mo-99 supply chain has historically depended on a small number of aging research reactors, and reactor outages have caused real clinical shortages. Robust QC plus contingency planning (alternate suppliers, calibration timing, and—where available—accelerator or neutron-based Mo-99) protect a department from both quality and availability failures. ⁹¹⁰¹¹

For context on how Tc-99m fits among the other radionuclides a department handles, see our overview of common PET and RPT isotopes.

Practical Tips

Elute on a predictable daily rhythm. Because the daughter peaks near 23 hours, a consistent morning elution captures near-maximum yield and makes day-to-day activity predictable for scheduling.
Do the breakthrough test on the first elution of the day, before dispensing. 10 CFR 35.204 ties the requirement to the first eluate; running it first means a failing generator is caught before any dose is drawn. ¹
Account for the rising ratio. Record the Mo-99/Tc-99m ratio and the assay time; for doses administered late in the day, confirm the ratio still clears 0.15 µCi/mCi at administration, not just at elution.
Read aluminum paper against the standard, not by eye alone. Color development is concentration-dependent; compare to the manufacturer's standard spot and document the result each elution.
Investigate trends, not just pass/fail. A breakthrough or aluminum value that is climbing elution-over-elution can signal channeling or column breakdown before it ever exceeds a limit—pull the trend, not just today's number.
Keep the dose calibrator honest. Every breakthrough measurement is only as good as the dose calibrator behind it; constancy, accuracy, linearity, and geometry checks underpin the QC.
Have a spill and contamination plan. A cracked vial or column failure is a contamination event—our decontamination best practices guide covers response.

Regulatory Considerations

Tc-99m and its Mo-99 parent are byproduct material, so they fall squarely under NRC authority: general radiation-protection standards in 10 CFR 20 and medical-use requirements in 10 CFR 35, with the specific generator rule in 10 CFR 35.204, "Permissible molybdenum-99, strontium-82, and strontium-85 concentrations." That section sets the 0.15 µCi Mo-99 per mCi Tc-99m limit at administration, requires the licensee to measure the Mo-99 concentration in the first eluate after receipt of a generator (and per the testing program thereafter), prohibits administering a dose exceeding the limit, and requires that records be kept for inspection. ¹ Program-level expectations—who may perform the test, instrument QC, recordkeeping, and reporting an out-of-limit result—are consolidated in NUREG-1556, Volume 9. ¹²

The pharmaceutical-quality side comes from the USP: the sodium pertechnetate Tc 99m injection monograph and supporting general chapters (radioactivity and radiopharmaceutical testing) define the aluminum limit, radiochemical purity, pH, and appearance acceptance criteria that complement the NRC's radionuclidic-purity rule. Professional guidance from SNMMI (and EANM internationally) describes how to operationalize these tests in routine nuclear pharmacy practice. ⁴⁸

Jurisdiction follows the usual byproduct-material pattern. Florida, Maryland, Virginia, California, and Nevada are NRC Agreement States whose radiation-control programs adopt and enforce the equivalent of 10 CFR 35.204, while Washington, DC is regulated directly by the NRC. DRPS supports clients across all six. For broader licensing context, see our NRC radioactive material license guide.

Frequently Asked Questions (FAQs)

What is the Mo-99 breakthrough limit for a Tc-99m generator?

The NRC limit in 10 CFR 35.204 is 0.15 microcurie of Mo-99 per millicurie of Tc-99m (0.15 kBq per MBq) at the time of administration. A licensee may not administer a dose that exceeds this ratio, and the first eluate of each elution day must be measured and recorded. ¹

How is Mo-99 breakthrough measured?

The eluate vial is placed in a lead shield (commonly about 6 mm of lead) that absorbs the 140 keV Tc-99m photons while transmitting the 740 and 778 keV Mo-99 photons, then assayed in a dose calibrator on the Mo-99 setting. The Mo-99 activity is divided by the Tc-99m activity from the unshielded vial to give the breakthrough ratio in µCi/mCi. ¹⁶

What is the aluminum breakthrough limit for a Tc-99m generator?

For fission-produced Mo-99 generators, the USP limit is no more than 10 micrograms of aluminum per milliliter of eluate. It is tested colorimetrically with aluminum indicator paper by comparing the developed spot color against a standard, on each elution. ⁴

How often must generator eluate be tested?

Mo-99 breakthrough is measured on the first eluate of each elution under 10 CFR 35.204; aluminum, radiochemical purity, pH, and appearance are checked per the USP monograph and the facility QC program. All results must be recorded and retained for NRC or Agreement State inspection. ¹⁴

Why does the Tc-99m generator have to sit before elution?

Tc-99m grows back in from its Mo-99 parent by transient equilibrium. After an elution strips the column, Tc-99m activity rebuilds and peaks about 23 hours later, so a generator eluted once daily is at near-maximum yield each morning. ²⁵

What is the difference between radionuclidic, radiochemical, and chemical purity?

Radionuclidic purity is the fraction of activity that is the correct radionuclide—degraded by Mo-99 breakthrough. Radiochemical purity is the fraction in the correct chemical form, such as pertechnetate rather than reduced or hydrolyzed technetium. Chemical purity concerns non-radioactive contaminants such as aluminum leached from the column. ⁴

Who regulates Tc-99m generators?

Tc-99m and Mo-99 are byproduct material regulated by the NRC under 10 CFR 20 and 10 CFR 35, including the 35.204 breakthrough limits. In Agreement States such as Florida, Maryland, Virginia, California, and Nevada, an equivalent state program enforces the same limits; Washington, DC is regulated directly by the NRC. ¹¹²

Key Takeaways

The Mo-99/Tc-99m generator separates daughter Tc-99m (T½ ≈ 6.0 h, 140 keV gamma) from parent Mo-99 (T½ ≈ 65.9 h) held on an alumina column, eluted with sterile saline to yield sodium pertechnetate Tc-99m injection.
Tc-99m rebuilds by transient equilibrium and peaks about 23 hours after a clean elution, which is why once-daily morning elution captures near-maximum yield.
The NRC limit (10 CFR 35.204) is 0.15 µCi Mo-99 per mCi Tc-99m (0.15 kBq/MBq) at administration, measured on the first eluate of each elution with a lead-shielded dose-calibrator assay; the ratio rises over the day as Tc-99m decays.
Aluminum breakthrough is capped at 10 µg/mL for fission generators and tested with aluminum indicator paper, because excess aluminum degrades labeling and biodistribution.
The three purities map onto the tests: radionuclidic (Mo-99 breakthrough), radiochemical (pertechnetate fraction via chromatography), and chemical (aluminum, pH, appearance).
Tc-99m is byproduct material under NRC 10 CFR 20/35, enforced equivalently by Agreement States (FL, MD, VA, CA, NV) and directly by the NRC in Washington, DC.

Conclusion

The Mo-99/Tc-99m generator turns a reactor product shipped once a week into a daily supply of the workhorse radionuclide of nuclear medicine, and the physics that makes it work—transient equilibrium with a ~23-hour buildup peak—also defines how it is used and tested. The quality-control panel run on every eluate is the bridge between that physics and patient safety: molybdenum breakthrough protects radionuclidic purity and caps patient dose, aluminum and radiochemical-purity testing protect image quality, and the whole program lives inside the NRC and USP framework. A department that understands both the buildup curve and the breakthrough ratio runs its generator safely, efficiently, and in compliance—even when the global Mo-99 supply chain is under strain.

How DRPS Can Help

DRPS provides board-certified diagnostic and nuclear medical physics support—generator and nuclear-pharmacy QC program design, dose calibrator and breakthrough-test procedures, radiation safety program development, ALARA optimization, and NRC and Agreement State compliance for medical use of byproduct material. Whether you are commissioning a new nuclear medicine service or tightening an existing generator QC program in Florida, Maryland, Virginia, Washington DC, California, or Nevada, our physicists help align your eluate testing with both 10 CFR 35.204 and USP expectations. New and expanding programs can pair this with PET/CT and nuclear medicine physics support and radioactive material license support. Contact DRPS to discuss your program.

Related Resources

References

U.S. Nuclear Regulatory Commission. 10 CFR 35.204: Permissible Molybdenum-99, Strontium-82, and Strontium-85 Concentrations. ecfr.gov
International Commission on Radiological Protection. ICRP Publication 107: Nuclear Decay Data for Dosimetric Calculations. Annals of the ICRP. 2008;38(3). icrp.org
International Atomic Energy Agency. Technetium-99m Radiopharmaceuticals: Manufacture of Kits. IAEA Technical Reports Series No. 466. Vienna: IAEA; 2008. iaea.org
United States Pharmacopeial Convention. Sodium Pertechnetate Tc 99m Injection monograph and General Chapter <821> Radioactivity. United States Pharmacopeia–National Formulary (USP–NF). usp.org
Eckerman KF, Endo A. MIRD: Radionuclide Data and Decay Schemes. 2nd ed. Reston, VA: Society of Nuclear Medicine and Molecular Imaging; 2008. snmmi.org
National Nuclear Data Center, Brookhaven National Laboratory. NuDat: Mo-99 and Tc-99m decay data. nndc.bnl.gov
Morley TJ, Dodd M, Gagnon K, et al. An automated module for the separation and purification of cyclotron-produced ^99mTcO₄^-. Nuclear Medicine and Biology. 2012;39(4):551-559. doi:10.1016/j.nucmedbio.2011.10.006. PubMed
Mitra A, Chattopadhyay S, Chandak A, et al. Clinical efficacy of sodium [^99mTc] pertechnetate from low specific activity ⁹⁹Mo/^99mTc autosolex generator in hospital radiopharmacy centre. Nuclear Medicine Review. 2020;23(1):1-14. doi:10.5603/NMR.a2020.0001. PubMed
Capogni M, Pietropaolo A, Quintieri L, et al. 14 MeV neutrons for ⁹⁹Mo/^99mTc production: experiments, simulations and perspectives. Molecules. 2018;23(8):1872. doi:10.3390/molecules23081872. PubMed
Welsh J, Bigles CI, Valderrabano A. Future U.S. supply of Mo-99 production through fission based LEU/LEU technology. Journal of Radioanalytical and Nuclear Chemistry. 2015;305(1):9-12. doi:10.1007/s10967-015-4090-9. PubMed
National Academies of Sciences, Engineering, and Medicine. Molybdenum-99 for Medical Imaging. Washington, DC: The National Academies Press; 2016. nap.nationalacademies.org
U.S. Nuclear Regulatory Commission. NUREG-1556, Volume 9, Revision 3: Consolidated Guidance About Materials Licenses — Program-Specific Guidance About Medical Use Licenses. nrc.gov